The company told the publication it is looking to expand from a 34,000-square-foot facility in New Castle to a 200,000-square-foot location near Newark. Accredo is looking to grow its fulfillment abilities, move shipping operations in-house, and address growth in the biosimilar and gene therapy drug markets.
While a lease for the facility is still under negotiation, the company hopes to have half the facility in operation by the end of next year. In September, the state approved a $4.62 million grant for the project.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
